Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Discovery programs R&D by Quarter
Discovery programs R&D (FY2018–FY2023 disaggregation) ($M) ($M)
Moderna Discovery programs R&D: $62M in Q3 2022, up 313.3% from a year earlier. That is the highest of the 8 quarters on record here. No newer figure appears in the documents we track.
Where the Q3 2022 figure comes from
“Discovery programs | 62 | 15 | 133 | 43”
Source: Q3 2022 10-Q ↗
Reported in Form 10-K / 10-Q Item 7 (MD&A R&D Breakdown).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Discovery programs R&D (FY2018–FY2023 disaggregation) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2022 | Sep 30, 2022 | 62 | +313.3% | Q3 2022 10-Q ↗ |
| Q2 2022 | Jun 30, 2022 | 41 | +173.3% | Q2 2022 10-Q ↗ |
| Q1 2022 | Mar 31, 2022 | 30 | +130.8% | Q1 2022 10-Q ↗ |
| Q3 2021 | Sep 30, 2021 | 15 | – | Q3 2022 10-Q ↗ |
| Q2 2021 | Jun 30, 2021 | 15 | – | Q2 2022 10-Q ↗ |
| Q1 2021 | Mar 31, 2021 | 13 | +30.0% | Q1 2022 10-Q ↗ |
| Q1 2020 | Mar 31, 2020 | 10 | -22.6% | Q1 2021 10-Q ↗ |
| Q1 2019 | Mar 31, 2019 | 12.9 | – | Q1 2020 10-Q ↗ |
Cite this data
StockData. (2026). Moderna Discovery programs R&D ($M), quarterly Q1 2019–Q3 2022 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/rd-discovery-programs-leg
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.